Screening women with menorrhagia for underlying bleeding disorders: The utility of the platelet function analyser and bleeding time

Haemophilia

Volumn 11, Issue 5, 2005, Pages 497-503

  Philipp, Claire S ^a   Miller, C H ^b   Faiz, A ^a   Dilley, A ^b,c   Michaels, L A ^a   Ayers, C ^a   Bachmann, G ^a   Dowling, N ^b   Saidi, P ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b National Center for Birth Defects and Developmental Disabilities   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Bleeding time; Menorrhagia; Platelet dysfunction; Platelet function analyser; von Willebrand's disease

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; HEMOGLOBIN; PROTHROMBIN;

ADOLESCENT; ADULT; ANALYZER; ARTICLE; BLEEDING DISORDER; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HEMATOCRIT; HEMOSTASIS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MENORRHAGIA; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLEEDING TIME; BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; FEMALE; HUMANS; MASS SCREENING; MENORRHAGIA; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND DISEASE;

EID: 24644519808     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01129.x     Document Type: Article

References (29)

1. Kadir RA, Economides DL, Sabin C, Owens D, Lee C. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
2. Dilley A, Drew C, Miller C et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 2001; 97: 630-6.
3. Rees M. Menorrhagia. BMJ 1987; 294: 759-62.
4. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-8.
5. Philipp CS, Dilley A, Miller CH et al. Platelet functional defects in women with unexplained menorrhagia. J Thromb Haemost 2003; 1: 477-84.
6. James AH, Lukes AS, Brancazio L, Thames E, Ortel TL. Use of a new platelet function analyzer to detect von Willebrand disease in women with menorrhagia. Am J Obstet Gynecol 2004; 191: 449-55.
7. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001; 67: 125-9.
8. Bevan J, Maloney K, Hillery C, Gill J, Montgomery R, Paul S. Bleeding disorders: a common cause of menorrhagia in adolescents. J Pediatr 2001; 138: 856-61.
9. Saxena R, Gupta M, Gupta P, Kashyap R, Choudhry V, Bhargava M. Inherited bleeding disorders in Indian women with menorrhagia. Hemophilia 2003; 9: 193-6.
10. Philipp CS, Faiz A, Dowling N et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstet Gynecol 2005; 105: 61-6.
11. Duke WW. The pathogenesis of purpura hemorrhagica with special reference to the part played by blood platelets. Arch Intern Med 1912; 10: 445.
12. Ivy AC, Shapiro PF, Melnick P. The bleeding time in jaundice. Surg Gynecol Obstet 1935; 60: 781.
13. Harrison P. Progress in the assessment of platelet function. Br J Hematol 2000; 111: 733-44.
14. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Haemost 1995; 21: 106-12.
15. Mammen EF, Comp PC, Gosselin R et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Haemost 1998; 24: 195-202.
16. Francis J, Francis D, Larson L, Helms E, Garcia M. Can the platelet function analyzer (PFA-100 test substitute for the template bleeding time in routine clinical practice)? Platelets 1999; 10: 132-6.
17. ACOG Committee on Practice Bulletins-Gynecology. American College of Obstetricians and Gynecologists. ACOG practice bulletin: management of anovulatory bleeding. March 2000 (14). Int J Gynaecol Obstet 2001; 72: 263-71.
18. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
19. Janssen CAH, Scholten PC, Heintz APM. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85: 977-82.
20. Machin SJ, Preston E. Guidelines on platelet function testing. J Clin Pathol 1988; 41: 1322-30.
21. Hennekens CH, Buring JE. Epidemiology in Medicine, 1st edn. Boston, MA: Little Brown & Co., 1987.
22. Reid PC. Assessment of menstrual blood loss using a pictorial chart: a validation study. Br J Obstet Gynaecol 2000; 107: 320-2.
23. Fressinaud E, Veyradier A, Truchaud F et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91: 1325-31.
24. Cattaneo M, Frederici AB, Lecchi A et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82: 35-9.
25. Posan E, McBane RD, Grill DE, Motsko CL, Nichols WL. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 2003; 90: 483-90.
26. Moffat K, Ledford-Kraemer M, Nichols WL, Hayward C. Variability in clinical laboratory practice in testing for disorders of platelet function. Thromb Haemost 2005; 93: 549-53.
27. Harrison P. Measuring platelet function? Hematology 2004; 5: S164-9.
28. Cariappa R, Wilhite TR, Parvin CA, Luchtman-Jones L. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems. J Pediatr Hematol Oncol 2003; 25: 474-9.
29. Cattaneo M. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 1999; 96: 213-7.